ALFA Filings
Every announcement, straight from the exchange
Every Mankind Pharma debt & borrowing announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Mankind Pharma has successfully completed the interest payment and full redemption of its Non-Convertible Debentures due on October 16, 2026.
Mankind Pharma has fully redeemed its Non-Convertible Debentures, paying back the principal amount of ₹1,250 Crore on the maturity date.
Mankind Pharma Ltd confirmed payment of interest for its non-convertible debentures. This routine debt servicing update confirms the company has fulfilled its payment obligations.
Mankind Pharma approved a ₹150 Crore corporate guarantee in favour of banks for Bharat Serums and Vaccines Limited's credit facilities. This contingent liability supports BSV's operations.